Skip to content

WEZEL PHARMA

Active Private limited companyfounded 2020active for 6 yearsSt.-Jozefslaan 31, 2400 MolKBO/BCE: BE 0754.807.775

Lifetime

5 annual accounts with figures on one time axis
peak of €358,810 in 2021
€277,488▲ 21.9%
peak of €100,836 in 2022
€52,338▲ 122%
peak of €309,290 in 2025
€309,290▲ 20.4%
€211,348▼ 9.5%
peak of 2.7 FTE in 2021
2 FTEunchanged
Board1 name since 2020
1 director
Documentsfilings and deeds
02-07-202629 days before the deadline
2025abbreviated format
Gross margin from €227,657 to €277,488Result from €23,544 to €52,338Equity from €256,952 to €309,290Cash from €118,481 to €162,027

Key points

from the 2025 annual accounts

Equity

€309,290 ▲ 20.4%

WEZEL PHARMA has made a profit in every financial year since 2021.

Turnover

≈ €960,000 estimated

The abbreviated format states no turnover.

Staff

2 employees on 31-12-2025
312021012022232023102024112025

In 2025, 1 employee joined and 1 left.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as WEZEL PHARMA has now. Each dot stands for 68 companies, two years later.

94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for WEZEL PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 21-09-2020
  • 125 sharesdeed of 28-09-2020
  • 125 sharesdeed of 28-09-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0754807775
Incorporation Founding capital of €12,500, 250 shares · Founded by and · appointed as sole director · published on 28-09-2020 · Gazette deed
First establishment Apotheek Wezel, St.-Jozefslaan 31, Mol
All 10 events

Comparable companies

same main activity, similar in size and age
Company
WEZEL PHARMA Mol €520,638 €277,488 59.4% 2
Pharmacie BORN Flémalle €605,474 €290,523 47.2% 2
PHARMACIE MONFORT Beyne-Heusay €584,133 €254,807 20.0% 2.4
PHARMACIE DANTOIN Liège €535,094 €215,216 52.8% 1.7
PHARMACIE RIGO ROSETTE Spa €689,241 €245,245 37.6% 2.4
Apotheek De Bal Menen €719,624 €307,066 24.6% 1.7
PharmaSpace Ghent €495,059 €321,507 30.3% 2.4

These companies have the same main activity as WEZEL PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €495,000 and €720,000, founded between 2017 and 2021.

Official details

Source: KBO
Status
Active since 24-09-2020Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.307.820.0402400 Mol, since 24-09-2020
Financial year end
31 December
Peppol
Reachable since 27-01-2026
Company details

Annual accounts 2025

€520,638▲ 6.2%
Employeeson 31-12-2025
2=
Filing
Filed on 02-07-2026, 29 days before the end of the filing period
Financials

Insights on WEZEL PHARMA

WEZEL PHARMA files the abbreviated format. That format states no turnover. The gross margin fell from €358,810 in 2021 to €277,488 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about WEZEL PHARMA

What is the company number of WEZEL PHARMA?
The company number of WEZEL PHARMA is 0754.807.775. The VAT number is the same number with BE in front: BE 0754.807.775.
Where is WEZEL PHARMA based?
The registered office is at St.-Jozefslaan 31, 2400 Mol.Company details
What does WEZEL PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of WEZEL PHARMA?
WEZEL PHARMA is a private limited company (BV).
When was WEZEL PHARMA founded?
WEZEL PHARMA was founded on 24-09-2020.
Is WEZEL PHARMA still active?
Yes, WEZEL PHARMA is an active enterprise in the KBO register.
How many employees does WEZEL PHARMA have?
WEZEL PHARMA had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does WEZEL PHARMA fall under?
In its 2025 annual accounts, WEZEL PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of WEZEL PHARMA?
The turnover in financial year 2025 is ≈ €960,000. This figure is estimated from the gross margin of €277,488 and 42 comparable companies (NACE 477). It probably lies between €750,000 and €1.3m.
Is WEZEL PHARMA profitable?
In financial year 2025, WEZEL PHARMA made a profit of €52,338.
Where can I find the annual accounts of WEZEL PHARMA?
WEZEL PHARMA filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of WEZEL PHARMA due?
WEZEL PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.